Understanding nucleic acid sensing and its therapeutic applications

참고문헌 (218)

1. Marshall, J. S., "An introduction to immunology and immunopathology", Allergy Asthma Clin. Immunol, 14, pp.49~ (2018)
2. Iwasaki, A., "Control of adaptive immunity by the innate immune system", Nat. Immunol, 16, pp.343~353 (2015)
3. Wang, Y., "cGAS-STING pathway in cancer biotherapy", Mol. Cancer, 19, pp.136~ (2020)
4. Amouzegar, A., "STING agonists as cancer therapeutics", Cancers (Basel), 13 (2021)[DOI]
5. Yang, H., "cGAS is essential for cellular senescence", Proc. Natl Acad. Sci. USA, 114, pp.E4612~E4620 (2017)
6. McWhirter, S. M., "Nucleic acid sensors as therapeutic targets for human disease", Immunity, 53, pp.78~97 (2020)
7. Schlee, M., "Discriminating self from non-self in nucleic acid sensing", Nat. Rev. Immunol, 16, pp.566~580 (2016)
8. Okude, H., "Signaling through nucleic acid sensors and their roles in inflammatory diseases", Front. Immunol, 11, pp.625833~ (2020)
9. Kayraklioglu, N., "CpG oligonucleotides as vaccine adjuvants", Methods Mol. Biol, 2197, pp.51~85 (2021)
10. Zhang, C., "Advances in mRNA vaccines for infectious diseases", Front. Immunol, 10, pp.594~ (2019)
11. Berke, I. C., "Structural basis of innate immune recognition of viral RNA", Cell Microbiol, 15, pp.386~394 (2013)
12. Jelinek, I., "TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection", J. Immunol, 186, pp.2422~2429 (2011)
13. Sakaniwa, K., "TLR3 forms a laterally aligned multimeric complex along double-stranded RNA for efficient signal transduction", Nat. Commun, 14, pp.164~ (2023)
14. Miyake, K., "Nucleic acid sensing by toll-like receptors in the endosomal compartment", Front. Immunol, 13, pp.941931~ (2022)
15. Liu, G., "Distinct and orchestrated functions of RNA sensors in innate immunity", Immunity, 53, pp.26~42 (2020)
16. Kawasaki, T., "Discrimination between self and non-self-nucleic acids by the innate immune system", Int Rev. Cell Mol. Biol, 344, pp.1~30 (2019)
17. Rigby, R. E., "RNA : DNA hybrids are a novel molecular pattern sensed by TLR9", EMBO J, 33, pp.542~558 (2014)
18. Majer, O., "Nucleic acid-sensing TLRs : trafficking and regulation", Curr. Opin. Immunol, 44, pp.26~33 (2017)
19. Lind, N. A., "Regulation of the nucleic acid-sensing Toll-like receptors", Nat. Rev. Immunol, 22, pp.224~235 (2022)
20. Kim, Y. M., "UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes", Nature, 452, pp.234~238 (2008)
21. Lee, B. L., "Trafficking of endosomal Toll-like receptors", Trends Cell Biol, 24, pp.360~369 (2014)
22. Lee, B. L., "UNC93B1 mediates differential trafficking of endosomal TLRs", Elife, 2, pp.e00291~ (2013)
23. Park, B., "Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9", Nat. Immunol, 9, pp.1407~1414 (2008)
24. Blasius, A. L., "Intracellular toll-like receptors", Immunity, 32, pp.305~315 (2010)
25. Rimann, I., "The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid-sensing TLRs and ligands to endolysosomes", Proc. Natl Acad. Sci. USA, 119, pp.e2200544119~ (2022)
26. Heinz, L. X., "TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9", Nature, 581, pp.316~322 (2020)
27. Greulich, W., "TLR8 is a sensor of RNase T2 degradation products", Cell, 179, pp.1264~1275 (2019)
28. Liu, K., "Skewed endosomal RNA responses from TLR7 to TLR3 in RNase T2-deficient macrophages", Int. Immunol, 33, pp.479~490 (2021)
29. Henneke, M., "RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection", Nat. Genet, 41, pp.773~775 (2009)
30. Sisirak, V., "Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity", Cell, 166, pp.88~101 (2016)
31. Wilber, A., "Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection", Mol. Ther, 6, pp.35~42 (2002)
32. Al-Mayouf, S. M., "Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus", Nat. Genet, 43, pp.1186~1188 (2011)
33. Rodero, M. P., "Type I interferon-mediated autoinflammation due to DNase II deficiency", Nat. Commun, 8, pp.2176~ (2017)
34. Gavin, A. L., "PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing", Nat. Immunol, 19, pp.942~953 (2018)
35. Yoshida, H., "Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA", Nat. Immunol, 6, pp.49~56 (2005)
36. Santa, P., "The role of nucleases and nucleic acid editing enzymes in the regulation of self-nucleic acid sensing", Front. Immunol, 12, pp.629922~ (2021)
37. Bertheloot, D., "RAGE enhances TLR responses through binding and internalization of RNA", J. Immunol, 197, pp.4118~4126 (2016)
38. Ganguly, D., "Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8", J. Exp. Med, 206, pp.1983~1994 (2009)
39. Ivanov, S., "A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA", Blood, 110, pp.1970~1981 (2007)
40. Nguyen, T. A., "SIDT1 localizes to endolysosomes and mediates double-stranded RNA transport into the cytoplasm", J. Immunol, 202, pp.3483~3492 (2019)
41. Nguyen, T. A., "SIDT2 transports extracellular dsRNA into the cytoplasm for innate immune recognition", Immunity, 47, pp.498~509 (2017)
42. Wu, J, "Innate immune sensing and signaling of cytosolic nucleic acids", Annu. Rev. Immunol, 32, pp.461~488 (2014)
43. Kato, H., "Cell type-specific involvement of RIG-I in antiviral response", Immunity, 23, pp.19~28 (2005)
44. Yoneyama, M., "The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses", Nat. Immunol, 5, pp.730~737 (2004)
45. Kang, D. C., "Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5 : a novel type I interferon-responsive apoptosis-inducing gene", Oncogene, 23, pp.1789~1800 (2004)
46. Kowalinski, E., "Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA", Cell, 147, pp.423~435 (2011)
47. Vabret, N., "Sensing microbial RNA in the cytosol", Front. Immunol, 4, pp.468~ (2013)
48. Sanchez David, R. Y., "Comparative analysis of viral RNA signatures on different RIG-I-like receptors", Elife, 5, pp.e11275~ (2016)
49. Kato, H., "Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5", J. Exp. Med, 205, pp.1601~1610 (2008)
50. Wu, B., "Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5", Cell, 152, pp.276~289 (2013)
51. Liu, H. M., "The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity", Cell Host Microbe, 11, pp.528~537 (2012)
52. Lin, J. P., "The 14-3-3eta chaperone protein promotes antiviral innate immunity via facilitating MDA5 oligomerization and intracellular redistribution", PLoS Pathog, 15, pp.e1007582~ (2019)
53. Goubau, D., "Cytosolic sensing of viruses", Immunity, 38, pp.855~869 (2013)
54. Rothenfusser, S., "The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I", J. Immunol, 175, pp.5260~5268 (2005)
55. Saito, T., "Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2", Proc. Natl Acad. Sci. USA, 104, pp.582~587 (2007)
56. Quicke, K. M., "RNA helicase LGP2 negatively regulates RIG-I signaling by preventing TRIM25-mediated caspase activation and recruitment domain ubiquitination", J. Interferon Cytokine Res, 39, pp.669~683 (2019)
57. Bruns, A. M., "The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly", Mol. Cell, 55, pp.771~781 (2014)
58. Venkataraman, T., "Loss of DExD", H box RNA helicase LGP2 manifests disparate antiviral responses, 2007, pp.178, 6444~6455
59. Satoh, T., "LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses", Proc. Natl Acad. Sci. USA, 107, pp.1512~1517 (2010)
60. Gack, M. U., "TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity", Nature, 446, pp.916~920 (2007)
61. Oshiumi, H., "The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection", Cell Host Microbe, 8, pp.496~509 (2010)
62. Yan, J., "TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination", J. Mol. Cell Biol, 6, pp.154~163 (2014)
63. Kuniyoshi, K., "Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity", Proc. Natl Acad. Sci. USA, 111, pp.5646~5651 (2014)
64. Shen, Y., "Riok3 inhibits the antiviral immune response by facilitating TRIM40-mediated RIG-I and MDA5 degradation", Cell Rep, 35, pp.109272~ (2021)
65. Rehwinkel, J., "RIG-I-like receptors : their regulation and roles in RNA sensing", Nat. Rev. Immunol, 20, pp.537~551 (2020)
66. Hu, M. M., "Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5", J. Exp. Med, 214, pp.973~989 (2017)
67. Gack, M. U., "Phosphorylation-mediated negative regulation of RIG-I antiviral activity", J. Virol, 84, pp.3220~3229 (2010)
68. Seo, J., "O-linked N-acetylglucosamine modification of mitochondrial antiviral signaling protein regulates antiviral signaling by modulating its activity", Front. Immunol, 11, pp.589259~ (2020)
69. Lui, P. Y., "PACT facilitates RNA-induced activation of MDA5 by promoting MDA5 oligomerization", J. Immunol, 199, pp.1846~1855 (2017)
70. Kok, K. H., "The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response", Cell Host Microbe, 9, pp.299~309 (2011)
71. Lian, H., "The zinc-finger protein ZCCHC3 binds RNA and facilitates viral RNA sensing and activation of the RIG-I-like receptors", Immunity, 49, pp.438~448 (2018)
72. Oshiumi, H., "DDX60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation", Cell Rep, 11, pp.1193~1207 (2015)
73. Zhou, Z., "TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response", Proc. Natl Acad. Sci. USA, 111, pp.E245~E254 (2014)
74. Acharya, D., "Actin cytoskeleton remodeling primes RIG-I-like receptor activation", Cell, 185, pp.3588~3602 (2022)
75. Xu, L., "Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria", Proc. Natl Acad. Sci. USA, 106, pp.1530~1535 (2009)
76. Paget, M., "Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA", Mol. Cell, 83, pp.1180~1196 (2023)
77. Hao, Y., "ZBP1 : a powerful innate immune sensor and double-edged sword in host immunity", Int. J. Mol. Sci, 23 (2022)[DOI]
78. Chan, C. P., "Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations", RNA, 28, pp.449~477 (2022)
79. Bartok, E., "Immune sensing mechanisms that discriminate self from altered self and foreign nucleic acids", Immunity, 53, pp.54~77 (2020)
80. Samuel, C. E, "Adenosine deaminase acting on RNA(ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses", J. Biol. Chem, 294, pp.1710~1720 (2019)
81. Ishii, K. J., "A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA", Nat. Immunol, 7, pp.40~48 (2006)
82. Takaoka, A., "DAI(DLM-1", ZBP1)is a cytosolic DNA sensor and an activator of innate immune response, 2007, pp.448, 501~505
83. Chiu, Y. H., "RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway", Cell, 138, pp.576~591 (2009)
84. Hornung, V., "OAS proteins and cGAS : unifying concepts in sensing and responding to cytosolic nucleic acids", Nat. Rev. Immunol, 14, pp.521~528 (2014)
85. Gentili, M., "The N-terminal domain of cGAS determines preferential association with centromeric DNA and innate immune activation in the nucleus", Cell Rep, 26, pp.2377~2393 (2019)
86. Du, M, "DNA-induced liquid phase condensation of cGAS activates innate immune signaling", Science, 361, pp.704~709 (2018)
87. Zhou, W., "cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing", Mol. Cell, 81, pp.739~755 (2021)
88. Luecke, S., "cGAS is activated by DNA in a length-dependent manner", EMBO Rep, 18, pp.1707~1715 (2017)
89. Xie, W., "Human cGAS catalytic domain has an additional DNA-binding interface that enhances enzymatic activity and liquid-phase condensation", Proc. Natl Acad. Sci. USA, 116, pp.11946~11955 (2019)
90. Siddiqui, M. A., "Toll-like receptor(TLR)signaling enables cyclic GMP-AMP synthase(cGAS)sensing of HIV-1 infection in macrophages", mBio, 12, pp.e0281721~ (2021)
91. Yoh, S. M., "Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA", Mol. Cell, 82, pp.2871~2884 (2022)
92. Unterholzner, L., "IFI16 is an innate immune sensor for intracellular DNA", Nat. Immunol, 11, pp.997~1004 (2010)
93. Morrone, S. R., "Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy", Proc. Natl Acad. Sci. USA, 111, pp.E62~E71 (2014)
94. Jiang, Z., "IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection", Nat. Microbiol, 6, pp.932~945 (2021)
95. Sun, H., "A nuclear export signal is required for cGAS to sense cytosolic DNA", Cell Rep, 34, pp.108586~ (2021)
96. Almine, J. F., "IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes", Nat. Commun, 8, pp.14392~ (2017)
97. Warga, E., "Transcriptomic analysis of the innate immune response to in vitro transfection of plasmid DNA", Mol. Ther. Nucleic Acids, 31, pp.43~56 (2023)
98. Yum, S., "TBK1 recruitment to STING activates both IRF3 and NF-kappaB that mediate immune defense against tumors and viral infections", Proc. Natl Acad. Sci. USA, 118 (2021)[DOI]
99. Lee, M. N., "Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach", Nat. Immunol, 14, pp.179~185 (2013)
100. Hertzog, J., "Regulation and inhibition of the DNA sensor cGAS", EMBO Rep, 21, pp.e51345~ (2020)
101. Gao, D., "Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases", Proc. Natl Acad. Sci. USA, 112, pp.E5699~E5705 (2015)
102. Pokatayev, V., "RNase H2 catalytic core Aicardi-Goutieres syndrome-related mutant invokes cGAS-STING innate immune-sensing pathway in mice", J. Exp. Med, 213, pp.329~336 (2016)
103. Schumann, T., "Deficiency for SAMHD1 activates MDA5 in a cGAS", STING-dependent manner, 2023, pp.220, ~
104. Deng, Y., "Post-translational modifications of proteins in cytosolic nucleic acid sensing signaling pathways", Front. Immunol, 13, pp.898724~ (2022)
105. Chen, M., "TRIM14 inhibits cGAS degradation mediated by selective autophagy receptor p62 to promote innate immune responses", Mol. Cell, 64, pp.105~119 (2016)
106. Yang, X., "MARCH8 attenuates cGAS-mediated innate immune responses through ubiquitylation", Sci. Signal, 15, pp.eabk3067~ (2022)
107. Cai, X., "Opposing effects of deubiquitinase OTUD3 in innate immunity against RNA and DNA viruses", Cell Rep, 39, pp.110920~ (2022)
108. Song, Z. M., "KAT5 acetylates cGAS to promote innate immune response to DNA virus", Proc. Natl Acad. Sci. USA, 117, pp.21568~21575 (2020)
109. Dai, J., "Acetylation blocks cGAS activity and inhibits self-DNA-induced autoimmunity", Cell, 176, pp.1447~1460 (2019)
110. Hu, M. M., "Sumoylation promotes the stability of the DNA sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus", Immunity, 45, pp.555~569 (2016)
111. Cui, Y., "SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing", PLoS Pathog, 13, pp.e1006156~ (2017)
112. Seo, G. J., "Akt kinase-mediated checkpoint of cGAS DNA sensing pathway", Cell Rep, 13, pp.440~449 (2015)
113. Sun, X., "DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity", Nat. Commun, 11, pp.6182~ (2020)
114. Wang, X., "Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression", J. Clin. Invest, 133 (2023)[DOI]
115. Wang, Y., "The role of O-GlcNAcylation in innate immunity and inflammation", J. Mol. Cell Biol, 14 (2023)[DOI]
116. Hu, J., "Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation", Theranostics, 11, pp.805~823 (2021)
117. Li, T., "Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16", Proc. Natl Acad. Sci. USA, 109, pp.10558~10563 (2012)
118. Baker, P. J., "Posttranslational modification as a critical determinant of cytoplasmic innate immune recognition", Physiol. Rev, 97, pp.1165~1209 (2017)
119. Li, D., "IFI16 isoforms with cytoplasmic and nuclear locations play differential roles in recognizing invaded DNA viruses", J. Immunol, 207, pp.2699~2709 (2021)
120. Zhao, M., "The stress granule protein G3BP1 promotes pre-condensation of cGAS to allow rapid responses to DNA", EMBO Rep, 23, pp.e53166~ (2022)
121. Zhang, J., "ZYG11B potentiates the antiviral innate immune response by enhancing cGAS-DNA binding and condensation", Cell Rep, 42, pp.112278~ (2023)
122. Tao, X., "Ku proteins promote DNA binding and condensation of cyclic GMP-AMP synthase", Cell Rep, 40, pp.111310~ (2022)
123. Lian, H., "ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response", Nat. Commun, 9, pp.3349~ (2018)
124. Singh, R. S., "DDX41 is required for cGAS-STING activation against DNA virus infection", Cell Rep, 39, pp.110856~ (2022)
125. Saitoh, T., "Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response", Proc. Natl Acad. Sci. USA, 106, pp.20842~20846 (2009)
126. Lv, T., "Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression", J. Immunother. Cancer, 10 (2022)[DOI]
127. Ghosh, A., "Oligoadenylate-synthetase-family protein OASL inhibits activity of the DNA sensor cGAS during DNA virus infection to limit interferon production", Immunity, 50, pp.51~63 (2019)
128. Liao, C. Y., "PCBP1 modulates the innate immune response by facilitating the binding of cGAS to DNA", Cell Mol. Immunol, 18, pp.2334~2343 (2021)
129. Gu, H., "PCBP2 maintains antiviral signaling homeostasis by regulating cGAS enzymatic activity via antagonizing its condensation", Nat. Commun, 13, pp.1564~ (2022)
130. Orzalli, M. H., "cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection", Proc. Natl Acad. Sci. USA, 112, pp.E1773~E1781 (2015)
131. Jonsson, K. L., "IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP", Nat. Commun, 8, pp.14391~ (2017)
132. Li, D., "STING-mediated IFI16 degradation negatively controls type I interferon production", Cell Rep, pp.1249~1260 (2019)
133. Luteijn, R. D., "SLC19A1 transports immunoreactive cyclic dinucleotides", Nature, 573, pp.434~438 (2019)
134. Cordova, A. F., "Human SLC46A2 IS the Dominant cGAMP importer in extracellular cGAMP-sensing macrophages and monocytes", ACS Cent. Sci, 7, pp.1073~1088 (2021)
135. Zhou, C., "Transfer of cGAMP into bystander cells via LRRC8 volume-regulated anion channels augments STING-mediated interferon responses and anti-viral immunity", Immunity, 52, pp.767~781 (2020)
136. Wei, X., "LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon-mediated host antiviral immunity", Cell Rep, 39, pp.110880~ (2022)
137. Zhou, Y., "Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP", Immunity, 52, pp.357~373 (2020)
138. Pepin, G., "Connexin-dependent transfer of cGAMP to phagocytes modulates antiviral responses", mBio, 11 (2020)[DOI]
139. Maltbaek, J. H., "ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP", Immunity, 55, pp.1799~1812 (2022)
140. Carozza, J. A., "ENPP1’s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling", Proc. Natl Acad. Sci. USA, 119, pp.e2119189119~ (2022)
141. Zahid, A., "Molecular and structural basis of DNA sensors in antiviral innate immunity", Front Immunol, 11, pp.613039~ (2020)
142. Fuertes, M. B., "Type I interferon response and innate immune sensing of cancer", Trends Immunol, 34, pp.67~73 (2013)
143. Suter, M. A., "cGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells", Sci. Rep, 11, pp.7243~ (2021)
144. Wolff, J. A., "Direct gene transfer into mouse muscle in vivo", Science, 247, pp.1465~1468 (1990)
145. Miao, L., "mRNA vaccine for cancer immunotherapy", Mol. Cancer, 20, pp.41~ (2021)
146. Ishii, K. J., "TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines", Nature, 451, pp.725~729 (2008)
147. Coban, C., "Novel strategies to improve DNA vaccine immunogenicity", Curr. Gene Ther, 11, pp.479~484 (2011)
148. Kobiyama, K, "Making innate sense of mRNA vaccine adjuvanticity", Nat. Immunol, 23, pp.474~476 (2022)
149. Mu, X., "Immunogenicity of In Vitro-Transcribed RNA", Acc. Chem. Res, 54, pp.4012~4023 (2021)
150. Sprent, J., "COVID-19 vaccine side effects: The positives about feeling bad", Sci Immunol, 6 (2021)[DOI]
151. Miura, N., "A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant", Nucleic Acids Res, 43, pp.1317~1331 (2015)
152. Li, A., "Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy", J. Hematol. Oncol, 12, pp.35~ (2019)
153. Jeremiah, N., "RELA tunes innate-like interferon I", III responses in human T cells, 2023, pp.220, ~
154. Marcus, A., "Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response", Immunity, 49, pp.754~763 (2018)
155. Schadt, L., "Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity", Cell Rep, 29, pp.1236~1248 (2019)
156. Feng, X., "ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways", EMBO J, 39, pp.e104036~ (2020)
157. Du, S. S., "Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation", Int J. Radiat. Oncol. Biol. Phys, 112, pp.1243~1255 (2022)
158. Jesenko, T., "Radiation induced upregulation of DNA sensing pathways is cell-type dependent and can mediate the off-target effects", Cancers (Basel), 12 (2020)[DOI]
159. Tian, Z., "Cancer immunotherapy strategies that target the cGAS-STING pathway", Front. Immunol, 13, pp.996663~ (2022)
160. Jiang, Y., "Exploiting RIG-I-like receptor pathway for cancer immunotherapy", J. Hematol. Oncol, 16, pp.8~ (2023)
161. Skopelja-Gardner, S., "Role of the cGAS-STING pathway in systemic and organ-specific diseases", Nat. Rev. Nephrol, 18, pp.558~572 (2022)
162. Fu, J., "STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade", Sci. Transl. Med, 7, pp.283ra252~ (2015)
163. Heidegger, S., "RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade", EBioMedicine, 41, pp.146~155 (2019)
164. Liu, J., "PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity", Nat. Commun, 14, pp.2806~ (2023)
165. Ma, D., "Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response", Sci. Adv, 7 (2021)[DOI]
166. Boehmer, D. F. R., "OAS1", RNase L executes RIG-I ligand-dependent tumor cell apoptosis, 2021, pp.6, ~
167. Tudor, D., "TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines", Vaccine, 23, pp.1258~1264 (2005)
168. Moseman, E. A., "Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells", J. Immunol, 173, pp.4433~4442 (2004)
169. Baghban, R., "Nucleic acid-based vaccine platforms against the coronavirus disease 19 COVID-19", Arch. Microbiol, 205, pp.150~ (2023)
170. Stevenson, E. M., "SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8(+)T-cells", Nat. Commun, 13, pp.4888~ (2022)
171. Hemann, E. A., "A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity", J. Immunol, 210, pp.1247~1256 (2023)
172. Apostolico, J. S., "Poly(I : C)potentiates T cell immunity to a dendritic cell targeted HIV-multiepitope vaccine", Front. Immunol, 10, pp.843~ (2019)
173. Rodell, C. B., "TLR7", 8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy, 2018, pp.2, 578~588
174. Zhou, B., "RIG-I promotes cell death in hepatocellular carcinoma by inducing M1 polarization of perineal macrophages through the RIG-I", MAVS, Onco Targets Ther, pp.2020, 13[DOI]
175. Yang, R., "Emerging role of RNA sensors in tumor microenvironment and immunotherapy", J. Hematol. Oncol, 15, pp.43~ (2022)
176. Crowl, J. T., "Intracellular nucleic acid detection in autoimmunity", Annu. Rev. Immunol, 35, pp.313~336 (2017)
177. Jiang, X., "Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8+ T cells", J. Clin. Invest, 133 (2023)[DOI]
178. Zheng, W., "How the innate immune DNA sensing cGAS-STING pathway is involved in apoptosis", Int. J. Mol. Sci, 24 (2023)[DOI]
179. Kuhl, N., "STING agonism turns human T cells into interferon-producing cells but impedes their functionality", EMBO Rep, 24, pp.e55536~ (2023)
180. Murthy, A. M. V., "Crosstalk between cGAS-STING signaling and cell death", Cell Death Differ, 27, pp.2989~3003 (2020)
181. Gu, C., "Transfected DNA is targeted by STING-mediated restriction", Biochem. Biophys. Res. Commun, 549, pp.207~213 (2021)
182. Burke, J. M., "RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus", PLoS Pathog, 18, pp.e1010930~ (2022)
183. Zhang, F., "Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop", J. Biol. Chem, 276, pp.24946~24958 (2001)
184. Fleith, R. C., "IFIT3 and IFIT2", 3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA, 2018, pp.46, 5269~5285
185. Fang, E., "Advances in COVID-19 mRNA vaccine development", Signal Transduct. Target Ther, 7, pp.94~ (2022)
186. 김선창, "Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency", Molecular & Cellular Toxicology, 18(1), pp.1~8 (2022), 대한독성 유전단백체 학회[DOI]
187. Yang, B., "DNA vaccine for cancer immunotherapy", Hum. Vaccin. Immunother, 10, pp.3153~3164 (2014)
188. Lama, L., "Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression", Nat. Commun, 10, pp.2261~ (2019)
189. Zhang, S., "Potential Therapeutic Value of the STING Inhibitors", Molecules, 28 (2023)[DOI]
190. Wiser, C., "Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells", Sci. Rep, 10, pp.7604~ (2020)
191. Steinhagen, F., "Suppressive oligodeoxynucleotides containing TTAGGG motifs inhibit cGAS activation in human monocytes", Eur. J. Immunol, 48, pp.605~611 (2018)
192. Valentin, R., "Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2’-O-methyl gapmer oligonucleotides", Nucleic Acids Res, 49, pp.6082~6099 (2021)
193. Yu, H., "Battle royale: innate recognition of poxviruses and viral immune evasion", Biomedicines, 9 (2021)[DOI]
194. Chan, Y. K., "Viral evasion of intracellular DNA and RNA sensing", Nat. Rev. Microbiol, 14, pp.360~373 (2016)
195. El-Jesr, M., "Vaccinia virus activation and antagonism of cytosolic DNA sensing", Front. Immunol, 11, pp.568412~ (2020)
196. Eaglesham, J. B., "Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling", Nature, 566, pp.259~263 (2019)
197. Jaafar, Z. A., "Viral RNA structure-based strategies to manipulate translation", Nat. Rev. Microbiol, 17, pp.110~123 (2019)
198. Koliopoulos, M. G., "Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition", Nat. Commun, 9, pp.1820~ (2018)
199. Minnaert, A. K., "Vaccinia virus protein B18R : influence on mRNA immunogenicity and translation upon non-viral delivery in different ocular cell types", Pharmaceutics, 13 (2021)[DOI]
200. Wuebben, C., "Innate sensing of mRNA vaccines", Curr. Opin. Immunol, 79, pp.102249~ (2022)
201. Devarkar, S. C., "Structural basis for m7G recognition and 2’-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I", Proc. Natl Acad. Sci. USA, 113, pp.596~601 (2016)
202. Wesselhoeft, R. A., "Engineering circular RNA for potent and stable translation in eukaryotic cells", Nat. Commun, 9, pp.2629~ (2018)
203. Wesselhoeft, R. A., "RNA circularization diminishes immunogenicity and can extend translation duration in vivo", Mol. Cell, 74, pp.508~520 (2019)
204. Chen, Y. G., "N6-methyladenosine modification controls circular RNA immunity", Mol. Cell, 76, pp.96~109 (2019)
205. Moradian, H., "Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages", Mol. Ther. Nucleic Acids, 27, pp.854~869 (2022)
206. Wang, Y., "mRNA vaccine : a potential therapeutic strategy", Mol. Cancer, 20, pp.33~ (2021)
207. Mei, Y., "RNA modification in mRNA cancer vaccines", Clin. Exp. Med, 23, pp.1917~1931 (2023)
208. Eun Bi Cha, "Antibody-secreting macrophages generated using CpG-free plasmid eliminate tumor cells through antibody-dependent cellular phagocytosis", BMB Reports, 53(8), pp.442~447 (2020), 생화학분자생물학회[DOI]
209. Sheridan, C., "First COVID-19 DNA vaccine approved, others in hot pursuit", Nat. Biotechnol, 39, pp.1479~1482 (2021)
210. Tse, S. W., "mRNA-encoded, constitutively active STING(V155M)is a potent genetic adjuvant of antigen-specific CD8(+)T cell response", Mol. Ther, 29, pp.2227~2238 (2021)
211. Chen, Z., "An mRNA vaccine elicits STING-dependent antitumor immune responses", Acta Pharm. Sin. B, 13, pp.1274~1286 (2023)
212. Chen, J., "Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+)T cell response", Proc. Natl Acad. Sci. USA, 119, pp.e2207841119~ (2022)
213. Wang, Q., "STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer", Nat. Commun, 13, pp.3022~ (2022)
214. Parayath, N. N., "In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo", Nat. Commun, 11, pp.6080~ (2020)
215. Johnson, L. R., "The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function", Cell, 184, pp.4981~4995 (2021)
216. Anwar, S., "cGAS-STING-mediated sensing pathways in DNA and RNA virus infections : crosstalk with other sensing pathways", Arch. Virol, 166, pp.3255~3268 (2021)
217. Linares-Fernandez, S., "Tailoring mRNA vaccine to balance innate", adaptive immune response, 2020, pp.26, 311~323
218. Colombani, T., "704", DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates, 2023, pp.32, 743~757

관련 논문AI추천